ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD

C. Estornut (Valencia, Spain), I. Roger (Valencia, Spain), B. Ballester (Valencia, Spain), P. Ribera (Valencia, Spain), J. Cortijo (Valencia, Spain)

Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Session: Airway inflammation: pharmacological mechanisms and novel targets
Session type: Thematic Poster
Number: 4216

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Estornut (Valencia, Spain), I. Roger (Valencia, Spain), B. Ballester (Valencia, Spain), P. Ribera (Valencia, Spain), J. Cortijo (Valencia, Spain). ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD. 4216

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: